Personalis, Inc. (PSNL) stock
PSNLNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30379% above fair value
$15.71−0.15 (-0.95%)
Close on Nov 13, 2026Market cap $1.68BP/E –Yield –
Personalis gross margin
Gross margin is gross profit as a percentage of revenue.
Personalis's gross margin for the twelve months ending Sep 30, 2026 was 16.7%. For fiscal 2025 it was 22.7%, against 31.7% the year before. The highest annual figure on record is 37.0% in fiscal 2021.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 22.7% | −9.1 |
| FY2024 | Dec 31, 2024 | 31.7% | +6.9 |
| FY2023 | Dec 31, 2023 | 24.8% | +4.3 |
| FY2022 | Dec 31, 2022 | 20.5% | −16.5 |
| FY2021 | Dec 31, 2021 | 37.0% | +11.5 |
| FY2020 | Dec 31, 2020 | 25.6% | −8.3 |
| FY2019 | Dec 31, 2019 | 33.9% | +2.6 |
| FY2018 | Dec 31, 2018 | 31.3% | +56.2 |
| FY2017 | Dec 31, 2017 | -24.9% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 25.7% | +12.5 |
| Q2 FY2026 | Jun 30, 2026 | 21.2% | −6.4 |
| Q1 FY2026 | Mar 31, 2026 | 1.8% | −33.2 |
| Q4 FY2025 | Dec 31, 2025 | 11.0% | −16.1 |
| Q3 FY2025 | Sep 30, 2025 | 13.2% | −20.8 |
| Q2 FY2025 | Jun 30, 2025 | 27.6% | −7.9 |
| Q1 FY2025 | Mar 31, 2025 | 35.0% | +6.8 |
| Q4 FY2024 | Dec 31, 2024 | 27.1% | +0.6 |
| Q3 FY2024 | Sep 30, 2024 | 34.0% | +14.9 |
| Q2 FY2024 | Jun 30, 2024 | 35.6% | +6.9 |
| Q1 FY2024 | Mar 31, 2024 | 28.1% | +3.1 |
| Q4 FY2023 | Dec 31, 2023 | 26.5% | +12.6 |
| Q3 FY2023 | Sep 30, 2023 | 19.1% | +2.4 |
| Q2 FY2023 | Jun 30, 2023 | 28.7% | +5.2 |
| Q1 FY2023 | Mar 31, 2023 | 25.1% | −3.0 |
| Q4 FY2022 | Dec 31, 2022 | 13.8% | −24.8 |
| Q3 FY2022 | Sep 30, 2022 | 16.7% | −19.5 |
| Q2 FY2022 | Jun 30, 2022 | 23.5% | −14.2 |
| Q1 FY2022 | Mar 31, 2022 | 28.1% | −7.5 |
| Q4 FY2021 | Dec 31, 2021 | 38.7% | +8.6 |
| Q3 FY2021 | Sep 30, 2021 | 36.2% | +9.3 |
| Q2 FY2021 | Jun 30, 2021 | 37.7% | +13.7 |
| Q1 FY2021 | Mar 31, 2021 | 35.6% | +14.5 |
| Q4 FY2020 | Dec 31, 2020 | 30.1% | −6.1 |
| Q3 FY2020 | Sep 30, 2020 | 26.9% | −5.9 |
| Q2 FY2020 | Jun 30, 2020 | 24.0% | −13.3 |
| Q1 FY2020 | Mar 31, 2020 | 21.1% | −7.2 |
| Q4 FY2019 | Dec 31, 2019 | 36.2% | −0.5 |
| Q3 FY2019 | Sep 30, 2019 | 32.8% | −5.6 |
| Q2 FY2019 | Jun 30, 2019 | 37.3% | +10.1 |
| Q1 FY2019 | Mar 31, 2019 | 28.3% | +25.9 |
| Q4 FY2018 | Dec 31, 2018 | 36.7% | – |
| Q3 FY2018 | Sep 30, 2018 | 38.5% | – |
| Q2 FY2018 | Jun 30, 2018 | 27.2% | – |
| Q1 FY2018 | Mar 31, 2018 | 2.4% | – |
See a number that looks wrong?